|
Home | Medical-Newswire.Com:
|
(Medical-NewsWire.com, November 21, 2018 ) At F.Hoffmann-La Roche Ltd, they believe it’s urgent to deliver medical solutions right now – even as they develop innovations for the future. They are passionate about transforming patients’ lives. They are courageous in both decision and action. And they believe that good business means a better world. They commit to scientific rigor, unassailable ethics, and access to medical innovations for all. Their motto is “do this today to build a better tomorrow”.
Roche recently announced that it has completed the acquisition of Flatiron Health, a privately held healthcare technology and services company headquartered in New York City, US. Flatiron Health is a market leader in oncology-specific electronic health record (EHR) software as well as in the curation and development of real-world evidence for cancer research. With its large network of community oncology practices and academic medical centers across the US, Flatiron Health has created a technology platform designed to learn from the experience of every patient.
Get customized report here:
<||>rnhttps://www.marketdataforecast.com/market-reports/middle-east-and-africa-nucleic-acid-labelling-market-2940/customize-report
Market Trends:
Market Data Forecast has released a report on Middle East and Africa Nucleic Acid Labelling market; DNA sequencing occupies major share in terms of Applications due to its uses in identification of genetic disorders, tumour genetic variations. Reagents and Kits occupy major share among products segment due to their numerous uses in Diagnostic and Research Centres. Based on End User Research Centres occupy the major share owing to increasing government funding to increase research activity and drug discovery.
The Middle East and Africa Nucleic Acid Labelling Market was worth $110.54 million in 2016 and estimated to be growing at a CAGR of 8.97%, to reach $169.87 million by 2021.
Some of other key players dominating this market include Thermo Fisher Scientific, New England Biolabs, PerkinElmer, General Electric Company, Merck KGaA, Enzo Biochem, Promega Corporation, Vector Laboratories, and Agilent Technologies.
For the detailed information please follow the link:
<||>rnhttps://www.marketdataforecast.com/market-reports/middle-east-and-africa-nucleic-acid-labelling-market-2940/
Scope of the Report:
The report offers an extensive examination of the business by giving the estimations of market potential and gauges with most extreme granularity. Along this, the variables persuasive in affecting the market flow and patterns are examined in detail at the item level. Further, the execution of the market at the territorial and nation level is evaluated and the prospects with high development potential are distinguished and discussed.
The key players in the business are profiled giving bits of knowledge on their money related execution, advertise position and development techniques. Similar investigation on prime strategical exercises of the market players depicting the key advancements like mergers and acquisitions, coordinated efforts and an assessment of the focused condition inside the business are given. The report additionally offers an expansive standpoint of the market alongside proposals from industry specialists on the open doors for speculation action.
What else? Aside from the syndicated report, our in-house group has an aptitude and involvement in planning custom reports to meet your particular research needs and help you in settling on very much educated choices.
Market Data Forecast.
Abhishek Shukla
+1-888-702-9626
abhishek@marketdataforecast.com
Source: EmailWire.Com 
Source: EmailWire.com
|
|
|
|
